Argentina vs Norway: Number of isolates tested for ceftriaxone
Argentina
285
in 2020
Norway
450
in 2020
Argentina rank
11th
Norway rank
8th
Number of isolates tested for ceftriaxone over time
- Argentina
- Norway
How they compare
Norway currently reports 450 against 285 in Argentina, a difference of 165.
That makes Norway's figure about 1.6 times Argentina's.
The two have swapped places 1 time across 10 shared years of data; in 2009 it was Argentina ahead.
Argentina ranks 11th and Norway ranks 8th of 52 countries.
Across the 3 decades both report, Argentina averaged higher in 2 and Norway in 1.
Head to head by decade
| Decade | Argentina | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 310 | 110 | 200 | Argentina |
| 2010s | 610.62 | 99.88 | 510.75 | Argentina |
| 2020s | 285 | 450 | 165 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Argentina or Norway?
- Norway, at 450 against 285 in Argentina as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Argentina and Norway?
- 165, with Norway ahead.
- How many years of comparable data are there for Argentina and Norway?
- 10 years are reported by both, from 2009 to 2020.
- How do Argentina and Norway rank globally for number of isolates tested for ceftriaxone?
- Argentina ranks 11th and Norway ranks 8th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.